Since our founding in 2001, we have had one singular obsession: We strive to give our clients a personalized and collaborative research experience.

We are here to help you find the answers you need to develop the best possible drug candidate for treating patients with cancer and other diseases.

QUALITY SUPPORT

QUALITY ASSAYS

QUALITY DATA

Discovering Answers through Preclinical Research

Since 2001 we are passionate about offering contract research
to support the drug discovery community.

Company Facts

00

Clients worldwide

00

Research projects annually

00

Data points per year

00

Publication citations

00

Patent citations

Founded in 2001 in Malvern, Pennsylvania, Reaction Biology was created to provide outstanding kinase-based drug discovery to labs worldwide.
We have quickly become the go-to CRO for kinase screening and holding true to our promise for high-quality data and support we have continuously developed assays for new target classes. 20 years later, we offer thousands of assays and a platform for integrated drug discovery.
Our global footprint has grown to include three other research locations in Hershey, Pennsylvania (formerly vivoPharm, LLC), Freiburg, Germany (formerly ProQinase GmbH), and Heidelberg, Germany (Bioassay GmbH and Peptide Specialty Laboratories GmbH).

Malvern (Global HQ)

Malvern (Global HQ)
PA, USA

Hershey

Hershey
PA, USA

Freiburg

Freiburg
Freiburg, Germany

Heidelberg

Heidelberg
Heidelberg, Germany

Preclinical Drug Discovery Platform

Reaction Biology’s team of PhD scientists will take your drug discovery project from target validation through hit identification and hit to lead phases and provide lead optimization studies either on a fee-for-service basis or as integrated partner.

The CBC Network

We are proud to be part of the Chemical Biology Consortium (CBC) in the NCI Experimental Therapeutics (NExT) Program, which brings together chemical biologists and molecular oncologists from government, industry, and academia to create new cancer medicines in epigenetic, kinase, and other areas.

As a Specialized Center, we provide uniquely focused technologies that facilitate the successful progression of NExT discovery projects at specific discovery stages.

Beryllium Discovery Corp. (UCB)
University of California, San Francisco
Evotec Compound Management
SRI International
Sanford Burnham Prebys Medical Discovery Institute
The Scripps Research Institute
Vala Science Inc.
SAMDI Tech
Torrey Pines Institute for Molecular Studies
University of New Mexico
Arizona State University

Purdue University
University of Pittsburgh
Southern Research Institute
Albany Molecular Research Inc.
Xtal Bio Structures Inc.
Pharmaron
Reaction Biology Corp.
NCATS Chemical Genomics Center
University of North Carolina at Chapel Hill
Vanderbilt University
Emory University
University of Chicago